| |
|
|
|
Tonix Pharm Hld  
|
|
1.19 -0.03 (-0.02%) |
02-26 16:00 |
|
Open: |
1.24 |
Pre close: |
1.22 |
Target:
|
1.93
|
|
High: |
1.27 |
Low: |
1.12 |
Resistance:
|
1.65
2.12
|
|
Volume: |
16,051,802 |
Market Cap: |
385M |
Support:
|
0.89
0.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.23
 |
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
1.40  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
0.84 |
Stochastic Oscillator |
%K(14,3):
|
19.64 |
|
MA(250): |
0.82 |
%D(3): |
22.18 |
|
Average Volume(K) |
3-Month: |
4150603
|
52-Week |
High:
|
2.46 |
|
10-Days: |
2942696 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
45.97 |
Change(%): |
-12.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.331 |
Return on Equity (ttm) |
-116.4 |
Shares Out. (M) |
264.78 |
|
EPS Est. Current Year |
-3.020 |
Return on Assets (ttm) |
-66.1 |
Shares Float (M) |
156.47 |
|
EPS Est. Next Year |
-2.470 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.05 |
|
EPS Est. Next Quarter |
-0.740 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.25 |
|
Forward EPS |
-19.330 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
4430 |
|
Book Value (p.s.) |
0.450 |
EBITDA (p.s.) |
-0.159 |
P/E |
-3.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.64 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-41.34 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-30.98 |
P/CF |
-7.62 |
|
|
|
|
|
|
